Pharmacokinetics of Staccato Loxapine for Inhalation in Smokers Compared to Nonsmokers.

Trial Profile

Pharmacokinetics of Staccato Loxapine for Inhalation in Smokers Compared to Nonsmokers.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Loxapine (Primary)
  • Indications Agitation; Bipolar disorders; Migraine; Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 23 Jun 2009 Planned number of patients changed from 36 to 35 as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Status changed from recruiting to completed as reported byClinicalTrials.gov.
    • 14 Apr 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top